Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. GNK
6. USO
7. AWK
8. ARGX
9. AZN
10. SPCX

Go back to Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Kala Pharmaceuticals (KALA) Tops Q2 EPS by 6c

August 11, 2022 7:26 AM EDT

Kala Pharmaceuticals (NASDAQ: KALA) reported Q2 EPS of ($0.38), $0.06 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $2.02 million.

For earnings history and earnings-related data on Kala Pharmaceuticals (KALA) click here.

... More